TriangleNCT00534001 · OUTCOME
Abstinence
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 4 weeks
What was measured
Bioverified 4-week continuous abstinence
Groups in this outcome
Arm I (1-week run-in)
Participants receive an oral placebo once or twice daily in weeks 1-3 followed by oral bupropion hydrochloride once or twice daily in week 4. Participants also undergo 90-minute behavioral group counseling sessions once in weeks 1, 2, and 4. bupropion hydrochloride: Given orally placebo: Given orally
Arm II (4-week run-in)
Participants receive oral bupropion hydrochloride once or twice daily in weeks 1-4. Participants also undergo 90-minute behavioral group counseling sessions once in weeks 1, 2, and 4. bupropion hydrochloride: Given orally
| Group | Source count |
|---|---|
| Arm I (1-week run-in) | 48 |
| Arm II (4-week run-in) | 47 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (1-week run-in) | 25 | Not reported | Not reported | Not reported | Not reported |
| Arm II (4-week run-in) | 15 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 25
- group Id
- OG001
- value
- 15
- denoms
- counts
- group Id
- OG000
- value
- 48
- group Id
- OG001
- value
- 47
- units
- Participants
- description
- Bioverified 4-week continuous abstinence
- groups
- description
- Participants receive an oral placebo once or twice daily in weeks 1-3 followed by oral bupropion hydrochloride once or twice daily in week 4. Participants also undergo 90-minute behavioral group counseling sessions once in weeks 1, 2, and 4. bupropion hydrochloride: Given orally placebo: Given orally
- id
- OG000
- title
- Arm I (1-week run-in)
- description
- Participants receive oral bupropion hydrochloride once or twice daily in weeks 1-4. Participants also undergo 90-minute behavioral group counseling sessions once in weeks 1, 2, and 4. bupropion hydrochloride: Given orally
- id
- OG001
- title
- Arm II (4-week run-in)
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- 4 weeks
- title
- Abstinence
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice